Caterina Uberti‐Foppa

Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors

Marco Ripa, Laura Galli, Andrea Poli et al. · Clinical Microbiology and Infection · 2020 · 383 citations · Full text

Infectious Disease Epidemiology, Predictive Factors, Healthcare-associated Infection +12

Human Papillomavirus Infection and Associated Cervical Disease in Human Immunodeficiency Virus–Infected Women: Effect of Highly Active Antiretroviral Therapy

Flavia Lillo, Davide Ferrari, Fabrizio Veglia et al. · The Journal of Infectious Diseases · 2001 · 172 citations · Full text

Discontinuation of Secondary Prophylaxis against<i>Pneumocystis carinii</i>Pneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy

Bruno Ledergerber, Amanda Mocroft, Peter Reiss et al. · New England Journal of Medicine · 2001 · 168 citations · Full text

Safe Interruption of Maintenance Therapy against Previous Infection with Four Common HIV-Associated Opportunistic Pathogens during Potent Antiretroviral Therapy

Ole Kirk, Peter Reiss, Caterina Uberti‐Foppa et al. · Annals of Internal Medicine · 2002 · 136 citations

Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C

Roberta D’Ambrosio, L. Pasulo, Massimo Puoti et al. · Journal of Hepatology · 2018 · 130 citations

Vaccination, Hepatology, Hepatitis C +10